Glucotrol and Actinic keratosis - a phase IV clinical study of FDA data

Summary:

Actinic keratosis is found among people who take Glucotrol, especially for people who are male, 60+ old.

The phase IV clinical study analyzes which people take Glucotrol and have Actinic keratosis. It is created by eHealthMe based on reports of 19,975 people who have side effects when taking Glucotrol from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Mar, 22, 2023

19,975 people reported to have side effects when taking Glucotrol.
Among them, 17 people (0.09%) have Actinic keratosis.

What is Glucotrol?

Glucotrol has active ingredients of glipizide. It is often used in diabetes. eHealthMe is studying from 20,099 Glucotrol users for its effectiveness, alternative drugs and more.

What is Actinic keratosis?

Actinic keratosis (skin disease due to sun exposure) is found to be associated with 1,406 drugs and 894 conditions by eHealthMe.

Number of Glucotrol and Actinic keratosis reports submitted per year:

Could Glucotrol cause Actinic keratosis?

Gender of people who have Actinic keratosis when taking Glucotrol *:

female: 23.53 %
male: 76.47 %

Age of people who have Actinic keratosis when taking Glucotrol *:

Common drugs people take besides Glucotrol *:

Synthroid: 14 people, 82.35%
Glipizide: 13 people, 76.47%
Zometa: 10 people, 58.82%
Heparin Sodium: 10 people, 58.82%
Norvasc: 10 people, 58.82%
Metoclopramide: 10 people, 58.82%
Meperidine Hydrochloride: 10 people, 58.82%
Lotensin: 10 people, 58.82%
Lexapro: 10 people, 58.82%
Lansoprazole: 10 people, 58.82%

Common side effects people have besides Actinic keratosis *:

Weakness: 16 people, 94.12%
Fatigue (feeling of tiredness): 15 people, 88.24%
Nausea (feeling of having an urge to vomit): 15 people, 88.24%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 14 people, 82.35%
Stress And Anxiety: 14 people, 82.35%
Pollakiuria (abnormally frequent passage of relatively small quantities or urine): 14 people, 82.35%
Nausea And Vomiting: 13 people, 76.47%
Neck Pain: 13 people, 76.47%
Insomnia (sleeplessness): 13 people, 76.47%
Headache (pain in head): 13 people, 76.47%

Common conditions people have *:

Neoplasm Malignant (cancer tumour): 10 people, 58.82%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 2 people, 11.76%
Anaemia (lack of blood): 2 people, 11.76%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 1 person, 5.88%
Neuropathy Peripheral (surface nerve damage): 1 person, 5.88%
Joint Pain: 1 person, 5.88%
High Blood Pressure: 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Glucotrol and have Actinic keratosis?

Check whether Actinic keratosis is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Das S, Anand Ramasamy SD, Mondal S, "An unusual case of glipizide-induced proximal myopathy", Journal of pharmacology & pharmacotherapeutics, 2016 Jan .

Related studies

How severe was Actinic keratosis and when was it recovered:

Actinic keratosis in Glucotrol

Expand to all the drugs that have ingredients of glipizide:

Actinic keratosis and drugs with ingredients of glipizide (48 reports)

Alternative drugs to, pros and cons of Glucotrol:

Glucotrol (20,099 reports)

Common Glucotrol side effects:

Heart attack: 1,410 reports
Diabetes: 1,178 reports
Drug ineffective: 1,151 reports
Weakness: 1,132 reports
Pain: 1,065 reports

Browse all side effects of Glucotrol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Actinic keratosis treatments and more:

Actinic keratosis (8,691 reports)

COVID vaccines that are related to Actinic keratosis:

Common drugs associated with Actinic keratosis:

All the drugs that are associated with Actinic keratosis:

Actinic keratosis (1,406 drugs)

Common conditions associated with Actinic keratosis:

All the conditions that are associated with Actinic keratosis:

Actinic keratosis (894 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on glipizide (the active ingredients of Glucotrol) and Glucotrol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.